Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Kaidireyahan Wumaier, Wenqian Li & Jiuwei Cui. (2022) New Oral Anticoagulants Open New Horizons for Cancer Patients with Venous Thromboembolism. Drug Design, Development and Therapy 16, pages 2497-2507.
Read now
Read now
Inger Lise Gade, Marianne Tang Severinsen, Kristian Hay Kragholm, Søren Risom Kristensen, Christian Torp-Pedersen & Signe Juul Riddersholm. (2020) Epidemiology of Venous Thromboembolism After Second Cancer. Clinical Epidemiology 12, pages 377-386.
Read now
Read now
Thure Filskov Overvad, Torben Bjerregaard Larsen, Mette Søgaard, Ida Ehlers Albertsen, Anne Gulbech Ording, Simon Noble, Anette Arbjerg Højen & Peter Brønnum Nielsen. (2020) Cancer-associated venous thromboembolism and the non-vitamin K antagonist oral anticoagulants: a review of clinical outcomes and patient perspectives. Expert Review of Cardiovascular Therapy 18:11, pages 791-800.
Read now
Read now
Davide Imberti, Claudio Cimminiello, Marcello Di Nisio, Marco Marietta, Hernan Polo Friz & Walter Ageno. (2018) Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance. Expert Opinion on Pharmacotherapy 19:11, pages 1177-1185.
Read now
Read now
I. Elalamy & A. Falanga. (2018) Meeting Report EuroG20 Meeting on Cancer-Associated Thrombosis (CAT) Bergamo, Italy 7 April 2016. Cancer Investigation 36:1, pages 73-91.
Read now
Read now
Articles from other publishers (61)
Anna Falanga & Marina Marchetti. (2023) Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity. Journal of Thrombosis and Haemostasis 21:6, pages 1397-1408.
Crossref
Crossref
Tzu-Fei Wang, Alok A Khorana, Giancarlo Agnelli, Dan Bloomfield, Marc P Bonaca, Harry R Büller, Jean M Connors, Shinya Goto, Zhi-Cheng Jing, Ajay K Kakkar, Yasser Khder, Gary E Raskob, Gerald A Soff, Peter Verhamme, Jeffrey I Weitz & Marc Carrier. (2023) Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction. The Oncologist.
Crossref
Crossref
Katarina Glise Sandblad, Per-Olof Hansson, Jacob Philipson, Ahmad Mahmoud, Per Karlsson, Annika Rosengren & Jan Sörbo. (2023) Prevalence of Cancer in Patients with Venous Thromboembolism: A Retrospective Nationwide Case-Control Study in Sweden. Clinical and Applied Thrombosis/Hemostasis 29, pages 107602962311583.
Crossref
Crossref
Nicola Potere, Stefano Barco, Isabelle Mahé, Gabriela Cesarman‐Maus, Pantep Angchaisuksiri, Avi Leader, Helen C. Okoye, Edeghonghon Olayemi, Cihan Ay, Marc Carrier, Jean Marie Connors, Ioannis T. Farmakis, Riccardo M. Fumagalli, Zhi‐Cheng Jing, Lai Heng Lee, Claire McLintock, Fionnuala Ní Ainle, George Giannakoulas, Shinya Goto, Maria Cecilia Guillermo Esposito, Luis Jara‐Palomares, Marta Szlaszynska, Chee Wee Tan, Nick Van Es, Tzu‐Fei Wang, Beverley J. Hunt & Marcello Di Nisio. (2022) Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day. Journal of Thrombosis and Haemostasis 20:12, pages 2964-2971.
Crossref
Crossref
Nina Nouhravesh, Caroline Sindet-Pedersen, Thomas Kümler, Morten Schou, Morten K. Lamberts & Anette Arbjerg Højen. (2022) “No one told me anything about it and I cannot explain it”: Illness perception in symptomatic and asymptomatic patients with cancer-associated thrombosis. Thrombosis Research 220, pages 125-130.
Crossref
Crossref
Naima E. Benelhaj, Ann Hutchinson, Anthony Maraveyas & Miriam J. Johnson. (2022) Cancer patients’ experiences of the diagnosis and treatment of incidental pulmonary embolism (a qualitative study). PLOS ONE 17:10, pages e0276754.
Crossref
Crossref
Leanne Genge, Alexa Krala, Tobias Tritschler, Gregoire Le Gal, Nicole Langlois, Suzanne Dubois, Carol West, Lisa Duffett & Leslie Skeith. (2022) Evaluation of patients' experience and related qualitative outcomes in venous thromboembolism: A scoping review. Journal of Thrombosis and Haemostasis 20:10, pages 2323-2341.
Crossref
Crossref
Thura Win Htut, Kyaw Zin Thein, Kyaw Lwin Aung & Thein Hlaing Oo. (2022) Primary ambulatory thromboprophylaxis in patients with pancreatic cancer receiving chemotherapy: hope or hype?. Supportive Care in Cancer 30:10, pages 8511-8517.
Crossref
Crossref
M Carrier & TF Wang. (2022) The importance of consensus statements on the prevention and treatment of cancer-associated thrombosis. European Journal of Internal Medicine 100, pages 25-26.
Crossref
Crossref
Kathryn M. Musgrave, Kieron Power, Mike Laffan, James S. O’Donnell, Jecko Thachil & Anthony Maraveyas. (2022) Practical treatment guidance for cancer-associated thrombosis – Managing the challenging patient: A consensus statement. Critical Reviews in Oncology/Hematology 171, pages 103599.
Crossref
Crossref
L.A. Ciuffini, T.F. Wang, C. Lodigiani & M. Carrier. (2022) Thromboprophylaxis of cancer patients undergoing systemic therapy in the ambulatory setting. Best Practice & Research Clinical Haematology 35:1, pages 101351.
Crossref
Crossref
Alok A. Khorana, Nigel Mackman, Anna Falanga, Ingrid Pabinger, Simon Noble, Walter Ageno, Florian Moik & Agnes Y. Y. Lee. (2022) Cancer-associated venous thromboembolism. Nature Reviews Disease Primers 8:1.
Crossref
Crossref
Ilham Benzidia, Benjamin Crichi, Claire Montlahuc, Hanadi Rafii, Arlette N’Dour, Maxime Sebuhyan, Hélène Gauthier, Nassim Ait Abdallah, Philippe Benillouche, Stéphane Villiers, Christine Le Maignan & Dominique Farge. (2021) Effectiveness of a multidisciplinary care program for the management of venous thromboembolism in cancer patients: a pilot study. Journal of Thrombosis and Thrombolysis 53:2, pages 417-424.
Crossref
Crossref
Mercedes Salgado, Elena Brozos-Vázquez, Begoña Campos, Paula González-Villarroel, María Eva Pérez, María Lidia Vázquez-Tuñas & David Arias. (2022) Venous Thromboembolism In Cancer Patients: “From Evidence to Care”. Clinical and Applied Thrombosis/Hemostasis 28, pages 107602962210987.
Crossref
Crossref
Anna Falanga, Charis Girvalaki, Manuel Monreal, Jacob C Easaw & Annie Young. (2022) How well do European patients understand cancer-associated thrombosis? A patient survey. Cancer Treatment and Research Communications 31, pages 100557.
Crossref
Crossref
Barry Kevane & Ann Marie O'Neill. (2021) Venous Thromboembolism: The Patient Perspective. Thrombosis Update 5, pages 100082.
Crossref
Crossref
Alexander T. Cohen, Anthony Maraveyas, Jan Beyer-Westendorf, Agnes Y.Y. Lee, Kerstin Folkerts, Khaled Abdelgawwad, Yoriko De Sanctis, Samuel Fatoba, Luke Bamber, Miriam Bach & Lorenzo G. Mantovani. (2021) Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study. Thrombosis Research 206, pages 1-4.
Crossref
Crossref
M. Sebuhyan, B. Crichi, L. Deville, C. Le Maignan, C. Bonnet, Z. Marjanovic, J. Rueda, O. Bensaoula, A. Ndour, C. Frere, I. Madeleine & D. Farge. (2021) Patient education program at the forefront of cancer-associated thrombosis care. JMV-Journal de Médecine Vasculaire 46:5-6, pages 215-223.
Crossref
Crossref
Elin Baddeley, Anna Torrens‐Burton, Alisha Newman, Annmarie Nelson, Nikki Pease, Rosie Nelson & Simon Noble. (2021) A mixed‐methods study to evaluate a patient‐designed tool to reduce harm from cancer‐associated thrombosis: The EMPOWER study. Research and Practice in Thrombosis and Haemostasis 5:5, pages e12545.
Crossref
Crossref
Henriette Strøm Kahr, Ole B. Christiansen, Signe Juul Riddersholm, Inger L. Gade, Christian Torp‐Pedersen, Aage Knudsen & Ole Thorlacius‐Ussing. (2021) The timing of venous thromboembolism in ovarian cancer patients: A nationwide Danish cohort study. Journal of Thrombosis and Haemostasis 19:4, pages 992-1000.
Crossref
Crossref
Anette Arbjerg Højen, Thure Filskov Overvad, Mads Nybo, Thomas Kümler, Morten Schnack Rasmussen, Thomas Decker Christensen & Torben Bjerregaard Larsen. (2021) Management of Cancer-Associated Venous Thrombosis: A Nationwide Survey among Danish Oncologists. TH Open 05:02, pages e188-e194.
Crossref
Crossref
Zara Sayar, Anna Weatherill, Carolyn Gates & Mari Thomas. (2021) Use of anti-factor Xa levels in cancer patients taking direct oral anticoagulants. Thrombosis Research 200, pages 81-82.
Crossref
Crossref
Gary H. LymanMarc Carrier, Cihan AyMarcello Di NisioLisa K. HicksAlok A. KhoranaAndrew D. LeavittAgnes Y. Y. LeeFergus MacbethRebecca L. MorganSimon NobleElizabeth A. SextonDavid Stenehjem, Wojtek Wiercioch, Lara A. Kahale & Pablo Alonso-Coello. (2021) American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Advances 5:4, pages 927-974.
Crossref
Crossref
Hanno Riess, Peter Verhamme, Jeffrey I. Weitz, Annie Young, Rupert Bauersachs, Jan Beyer-Westendorf, Mark Crowther & Anthony Maraveyas. (2021) Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management. Critical Reviews in Oncology/Hematology 157, pages 103125.
Crossref
Crossref
Isabelle Mahé, Jean Chidiac, Mickaël Pinson, Michèle Pinson, Parinita Swarnkar, Annmarie Nelson & Simon Noble. (2020) Patients experience of living with cancer associated thrombosis in France (Le PELICAN). Thrombosis Research 194, pages 66-71.
Crossref
Crossref
Marc Carrier & Tzu-Fei Wang. (2020) Direct oral anticoagulants and cancer-associated VTE: good for all, or just some?. Blood 136:6, pages 669-673.
Crossref
Crossref
M. Carrier. (2020) Debate: Thromboprophylaxis should be considered in all patients with cancer – Yes. Thrombosis Research 191, pages 142-144.
Crossref
Crossref
Anthony Maraveyas. (2020) Latest advances in preventing thromboembolic disease in the ambulatory oncology patient. Thrombosis Research 191, pages S91-S98.
Crossref
Crossref
Silvia Riondino, Patrizia Ferroni, Girolamo Del Monte, Vincenzo Formica, Fiorella Guadagni & Mario Roselli. (2020) Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care. Cancers 12:5, pages 1167.
Crossref
Crossref
Camilla Sødequist, Susanne S. Pedersen, Ann Bøcher Secher Banke & Nina Rottmann. (2020) Living with the dilemma of the treatment for human epidermal growth factor receptor 2‐positive breast cancer and the risk of incident heart disease: A qualitative investigation of patients' experiences. European Journal of Cancer Care 29:3.
Crossref
Crossref
Tracey Woulfe, Kiri Mann, Daryl Pollack, Parinita Swarnkar, Annmarie Nelson & Simon Noble. (2020) “Wolverine, I think it's called: Blood thinners but in tablets.” Patients experience of living with cancer associated thrombosis in New Zealand (PELICANZ). Thrombosis Research 189, pages 35-38.
Crossref
Crossref
Frits I. Mulder, Floris T. M. Bosch & Nick van Es. (2020) Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We Stand?. Cancers 12:2, pages 367.
Crossref
Crossref
P. Debourdeau, P. Arvers, A. Hij, H. Bennani, C. Desauw, N. Falvo, F. Ghiringhelli, A. Hamadé, L. Vedrine & D. Farge. (2019) Factors influencing patient’s perception of long-term treatment with low-molecular-weight heparins for cancer-associated thrombosis: an updated analysis of TROPIQUE, a prospective observational study. Supportive Care in Cancer 28:1, pages 287-293.
Crossref
Crossref
Simon Noble, Annmarie Nelson, Jill Scott, Anne Berger, Karen Schmidt, Parinita Swarnkar & Agnes Lee. (2020) Patient Experience of Living With Cancer‐Associated Thrombosis in Canada (PELICANADA). Research and Practice in Thrombosis and Haemostasis 4:1, pages 154-160.
Crossref
Crossref
Lucia Marin-Barrera, Andres J. Muñoz-Martin, Eduardo Rios-Herranz, Ignacio Garcia-Escobar, Carmen Beato, Carme Font, Estefania Oncala-Sibajas, Alfonso Revuelta-Rodriguez, Maria Carmen Areses, Victor Rivas-Jimenez, Maria Angeles Moreno-Santos, Aitor Ballaz-Quincoces, Juan-Bosco Lopez-Saez, Iria Gallego, Teresa Elias-Hernandez, Maria Isabel Asensio-Cruz, Leyre Chasco-Eguilaz, Gonzalo Garcia-Gonzalez, Purificacion Estevez-Garcia, Remedios Otero, Jorge Lima-Alvarez & Luis Jara-Palomares. (2019) A Case-Control Analysis of the Impact of Venous Thromboembolic Disease on Quality of Life of Patients with Cancer: Quality of Life in Cancer (Qca) Study. Cancers 12:1, pages 75.
Crossref
Crossref
Emma Gee, Lara Roberts, Roopen Arya & Vicki Tsianakas. (2019) Patient experience of pregnancy-related venous thrombosis: A phenomenological study. Thrombosis Research 183, pages 86-90.
Crossref
Crossref
Iva Golemi, Juan P. Salazar Adum, Luis Diaz Quintero, Luis H. Paz, Harry E. Fuentes, Natalie Schmitt & Alfonso J. Tafur. (2019) Gaps of care in patients with venous thrombotic embolism: a qualitative study. International Angiology 38:4.
Crossref
Crossref
Pia Paffenholz, Katharina Grein, Isabel Heidegger, Tim Nestler, Markus Grabbert, Johannes Salem, Martin Hellmich, David Pfister & Axel Heidenreich. (2018) Predictors of thrombosis in testicular cancer during platinum-based chemotherapy. World Journal of Urology 37:9, pages 1907-1916.
Crossref
Crossref
Aurelien Delluc, Tzu‐Fei Wang, Eng‐Soo Yap, Cihan Ay, Jordan Schaefer, Marc Carrier & Simon Noble. (2019) Anticoagulation of cancer patients with non‐valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis 17:8, pages 1247-1252.
Crossref
Crossref
Zara Sayar, Julia Czuprynska, Jignesh P. Patel, Reuben Benjamin, Lara N. Roberts, Raj K. Patel, Victoria Cornelius & Roopen Arya. (2019) What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trial. Journal of Thrombosis and Thrombolysis 48:2, pages 315-322.
Crossref
Crossref
Simon Noble. (2019) Venous thromboembolism and palliative care. Clinical Medicine 19:4, pages 315-318.
Crossref
Crossref
Jacob C Easaw, Susan McCall & Adrian Azim. (2018) ClotAssist: A program to treat cancer-associated thrombosis in an outpatient pharmacy setting. Journal of Oncology Pharmacy Practice 25:4, pages 818-823.
Crossref
Crossref
Ann Hutchinson, Sophie Rees, Annie Young, Anthony Maraveyas, Kathryn Date & Miriam J Johnson. (2018) Oral anticoagulation is preferable to injected, but only if it is safe and effective: An interview study of patient and carer experience of oral and injected anticoagulant therapy for cancer-associated thrombosis in the select-d trial. Palliative Medicine 33:5, pages 510-517.
Crossref
Crossref
Zibi Marchocki, Lucy Norris, Sharon O'Toole, Noreen Gleeson & Feras Abu Saadeh. (2019) Patients’ experience and compliance with extended low molecular weight heparin prophylaxis post-surgery for gynecological cancer: a prospective observational study. International Journal of Gynecologic Cancer 29:4, pages 802-809.
Crossref
Crossref
Simon Noble. 2019. Textbook of Palliative Care. Textbook of Palliative Care
1297
1316
.
Alexander T. Cohen, Anthony Maraveyas, Jan Beyer-Westendorf, Agnes Y. Y. Lee, Lorenzo G. Mantovani & Miriam Bach. (2018) COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study. Thrombosis Journal 16:1.
Crossref
Crossref
Inger Lise GadeSigne Juul Riddersholm, Ilse ChristiansenAnnika RewesMikael FrederiksenLisbeth EnggaardChristian Bjørn PoulsenOlav Jonas BergmannDorte Balle GillströmRobert Schou PedersenLinda Nielsen, Helle Højmark Eriksen, Christian Torp-Pedersen, Søren Risom Kristensen & Marianne Tang Severinsen. (2018) Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study. Blood Advances 2:21, pages 3025-3034.
Crossref
Crossref
A.A. Khorana, S. Noble, A.Y.Y. Lee, G. Soff, G. Meyer, C. O'Connell & M. Carrier. (2018) Role of direct oral anticoagulants in the treatment of cancer‐associated venous thromboembolism: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis 16:9, pages 1891-1894.
Crossref
Crossref
Carme Font, Annmarie Nelson, Tanya Garcia-Fernandez, Hayley Prout, Peter Gee & Simon Noble. (2018) Patients’ Experience of Living with Cancer-associated thrombosis in Spain (PELICANOS). Supportive Care in Cancer 26:9, pages 3233-3239.
Crossref
Crossref
Naima B Benelhaj, Ann Hutchinson, Anthony M Maraveyas, Julie D Seymour, Muhammad Waqas Ilyas & Miriam J Johnson. (2018) Cancer patients’ experiences of living with venous thromboembolism: A systematic review and qualitative thematic synthesis. Palliative Medicine 32:5, pages 1010-1020.
Crossref
Crossref
Isabelle Mahé, Ygal Benhamou, Hélène Helfer & Jean Chidiac. (2018) Cancer et récidive thromboembolique veineuse : les clés d’une prise en charge optimale. Bulletin du Cancer 105:5, pages 508-516.
Crossref
Crossref
Simon Noble. 2018. Textbook of Palliative Care. Textbook of Palliative Care
1
20
.
Agnes Y. Y. Lee. (2017) When can we stop anticoagulation in patients with cancer-associated thrombosis?. Hematology 2017:1, pages 128-135.
Crossref
Crossref
Agnes Y. Y. Lee. (2017) When can we stop anticoagulation in patients with cancer-associated thrombosis?. Blood 130:23, pages 2484-2490.
Crossref
Crossref
Inger Lise Gade, Sigrid Brækkan, Inger Anne Næss, John-Bjarne Hansen, Frits Rosendaal, Suzanne Cannegieter, Kim Overvad, Hilde Jensvoll, Jens Hammerstrøm, Olga Vikhammer Gran, Anne Tjønneland, Søren Risom Kristensen & Marianne Tang Severinsen. (2017) Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort. Thrombosis Research 158, pages 157-160.
Crossref
Crossref
Alannah Smrke & Peter L. Gross. (2017) Cancer-Associated Venous Thromboembolism: A Practical Review Beyond Low-Molecular-Weight Heparins. Frontiers in Medicine 4.
Crossref
Crossref
I.L. Gade, S.K. Brækkan, I.A. Næss, J.‐B. Hansen, S.C. Cannegieter, K. Overvad, H. Jensvoll, J. Hammerstrøm, K. Blix, A. Tjønneland, S.R. Kristensen & M.T. Severinsen. (2017) The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort. Journal of Thrombosis and Haemostasis 15:8, pages 1567-1575.
Crossref
Crossref
Lisa Duffett. (2017) Patient engagement: What partnering with patient in research is all about. Thrombosis Research 150, pages 113-120.
Crossref
Crossref
I. Mahé, J. Chidiac, H. Helfer & S. Noble. (2016) Factors influencing adherence to clinical guidelines in the management of cancer‐associated thrombosis. Journal of Thrombosis and Haemostasis 14:11, pages 2107-2113.
Crossref
Crossref
Simon Noble. (2016) Thromboembolic disease and breathlessness. Current Opinion in Supportive & Palliative Care 10:3, pages 249-255.
Crossref
Crossref
Simon Noble & Jessica Sui. (2016) The treatment of cancer associated thrombosis: does one size fit all? Who should get LMWH/warfarin/DOACs?. Thrombosis Research 140, pages S154-S159.
Crossref
Crossref